The burden of cervical cancer is disproportionately distributed globally, with the vast majority
of cases occurring in low-and middle-income countries. Women with human …

Introduction. Cervical cancer is caused by infection with human papillomavirus (HPV).
Several countries have implemented vaccination programs against HPV for teenage girls …

Human papillomavirus (HPV) vaccines are available in the United States and around the
world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV …

Human papillomavirus (HPV) is a critical factor in the development of cervical cancer and
can lead to genital warts and other clinical sequelae. Two vaccines against HPV have been …

On October 16, 2009, the Food and Drug Administration licensed quadrivalent human
papillomavirus vaccine (HPV4; Gardasil, Merck & Co. Inc.) for use in males aged 9 through …

BACKGROUND: Cervical cancer remains an important health problem even in countries
with effec-tive cervical screening programs. HPV vaccines offer great potential for primary …

Background: Eradicating genital warts through HPV immunization could decrease STD clinic
utilization but may result in missed opportunities to diagnose other STDs. Objectives: To …

This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Genital human papillomavirus (HPV) infection and HPV‐associated cervical and other
anogenital cancers are significant public health problems. HPV 16 and HPV 18 are …

Cervical cancer prevention is expected to be achieved by vaccination of girls 2‑3 years
before sexual debut, and cervical smear cytology follow‑up. The existing human …